Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Valeo Pharma Inc T.VPH

Alternate Symbol(s):  VPHIF | T.VPH.DB

Valeo Pharma Inc. is a Canada-based specialty pharmaceutical company. The Company acquires or in-licenses brand and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology, specialty products, hospital generic division. Its respiratory/allergy products include Enerzair... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:VPH)

VALEO PHARMA REPORTS RECORD THIRD QUARTER 2023 REVENUES

Canada NewsWire 9 days ago

VALEO PHARMA TO HOST THIRD QUARTER 2023 RESULTS CONFERENCE CALL / WEBCAST

Canada NewsWire September 7, 2023

VALEO PHARMA CLOSES $4.5 MILLION FINANCING

Canada NewsWire August 31, 2023

VALEO PHARMA PROVIDES UPDATE ON OPHTHALMOLOGY BUSINESS UNIT

Canada NewsWire July 4, 2023

VALEO PHARMA ANNOUNCES NEW BOARD APPOINTMENTS

Canada NewsWire June 22, 2023

VALEO PHARMA REPORTS RECORD SECOND QUARTER REVENUES

Canada NewsWire June 13, 2023

VALEO PHARMA TO HOST SECOND QUARTER 2023 RESULTS CONFERENCE CALL / WEBCAST

Canada NewsWire June 7, 2023

VALEO PHARMA PROVIDING GUIDANCE OF RECORD REVENUES FOR THE SECOND QUARTER 2023

Canada NewsWire May 25, 2023

VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS AND COMMITTEE APPOINTMENTS

Canada NewsWire April 28, 2023
View More News ››

Opinion & Analysis (TSX:VPH)

Valeo Pharma, CureVac, Moderna, Sartorius: high-flyers or latecomers?

Nico Popp December 9, 2020

BioNTech, Bayer, Valeo Pharma: Share price jump ahead of quarterly results

Stockhouse Editorial September 29, 2020

BioNTech, CureVac, or Valeo Pharma: who brings the highest return to shareholders?

Stockhouse Editorial September 23, 2020

BioNTech, CureVac, Valeo Pharma - Growth after capital injection

Stockhouse Editorial September 11, 2020

Desert Gold, dynaCERT, Valeo Pharma - good news and the right time

Stockhouse Editorial September 3, 2020

Valeo Pharma In-Play, New HesperCo™ Immune System Support Scientifically Demonstrated

Stockhouse Editorial September 2, 2020
View More Opinion ››

Bullboard Posts (TSX:VPH)

UPDATE ON OPHTHALMOLOGY BUSINESS UNIT T.VPH

Novartis agrees to sell global rights to XIIDRA® and several other ophthalmology products to Baucsh + Lomb SIMBRINZA®...
Betteryear2 - July 4, 2023

VALEO PHARMA REPORTS RECORD SECOND QUARTER REVENUES

VALEO PHARMA REPORTS RECORD SECOND QUARTER REVENUES - Valeo Pharma
NonoRobotSG - June 15, 2023

VPH: To profit from forest fires!

VPH sells products with a focus on Respiratory/Allergy.
Royal10 - June 6, 2023

VPH: ECHELON's target price: $1.00!

Valeo Pharma trades at 55 cents today. The co will report its Q1/23 results after the close today! I am very anxious to see these results...
Royal10 - March 15, 2023

RE:VPH: Announces higher revenue guidance for Q4/2022.

Technically , VPH could potentially double in the next few weeks. Simple Moving Avg (30) ——Simple Moving Avg (90) ——
Royal10 - November 15, 2022

VPH: Announces higher revenue guidance for Q4/2022.

VALEO PHARMA RAISES Q4 AND FULL YEAR 2022 REVENUE GUIDANCE Valeo Pharma Inc. has raised revenue guidance for its fourth quarter of...
Royal10 - November 15, 2022
View more Bullboard ››

Sprout AI Inc

Sprout AI Inc

Sprout AI Inc. is primarily engaged in vertical farming technology. The Company is in the business of planning, designing ...
View More »